Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/46361
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSoysal, Ergun-
dc.contributor.authorUlutas, Firdevs-
dc.contributor.authorTepeli, Emre-
dc.contributor.authorKaymaz, Serdar-
dc.contributor.authorCobankara, Veli-
dc.date.accessioned2023-01-09T21:11:01Z-
dc.date.available2023-01-09T21:11:01Z-
dc.date.issued2022-
dc.identifier.issn0172-8172-
dc.identifier.issn1437-160X-
dc.identifier.urihttps://doi.org/10.1007/s00296-021-04881-9-
dc.identifier.urihttps://hdl.handle.net/11499/46361-
dc.description.abstractRheumatoid arthritis (RA) is a common autoimmune disease in which many different genetic variants of functional gene polymorphisms may play a culprit role in the underlying pathogenetic mechanism. The recent studies suggest that interleukin-23 receptor (IL-23R) gene polymorphisms may increase susceptibility to the development of various autoimmune diseases. We aimed to examine the possible relationship of nine single nucleotide polymorphisms (SNPs) in the IL-23R gene to susceptibility to rheumatoid arthritis and their associations with disease characteristics in the South Aegean region of Turkey. We enrolled 100 rheumatoid arthritis patients and age- and sex-matched 96 healthy subjects in the study. After deoxyribonucleic acid (DNA) isolation was performed, a 'Restriction Fragment Length Polymorphism' (RFLP) method was used for the investigation of polymorphisms associated with the IL-23R gene. Allele identification and genotyping were obtained from polymerase chain reaction (PCR) products using gel electrophoresis. Allele frequencies and detected genotypes were compared between groups. All statistical analyses were performed using SPSS 25.0 (IBM SPSS Statistics 25 software (Armonk, NY: IBM Corp.)). Continuous variables were defined by the mean +/- standard deviation and categorical variables were defined by number and percent. Logistic Regression Analysis was used for determining which variables affect the presence of RA. Differences between categorical variables were analyzed with Chi-square analysis. Statistical significance was determined as p < 0.05. The mean age was 53.48 +/- 11.7 years in the RA group, whereas 52.55 +/- 12.7 years in the healthy control group. The genotypes of IL-23R with rs11805303(TT), rs10889677(AA), rs1004819(AA), and rs7530511(CT) polymorphisms were seen more often in RA patients than healthy controls. Having the AA genotype of IL-23R rs1004819 and the CT genotype of Il-23R rs7530511 increase the development risk of RA with a statistical significance (OR: 3.416 p = 0.003 and OR: 4.899 p = 0.0001, respectively). RA patients with the CC genotype of Il-23R with rs11805303, the CC genotype with rs10889677, and the TT genotype with rs2201841 of the IL-23R gene had higher erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels than with other genotypes. RA patients with the CC genotype rs11805303 and the GG genotype rs1004819 of the IL-23R gene had more active disease. Our findings suggest that all of the nine analyzed IL-23R gene polymorphisms are seen more frequently than healthy controls in our study population. Besides, some SNPs were related to higher acute phase reactants and higher disease activity scores.en_US
dc.language.isoenen_US
dc.publisherSpringer Heidelbergen_US
dc.relation.ispartofRheumatology Internationalen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRheumatoid arthritisen_US
dc.subjectInterleukin 23 receptoren_US
dc.subjectGene polymorphismsen_US
dc.subjectInterleukin-23en_US
dc.subjectDiseaseen_US
dc.subjectSusceptibilityen_US
dc.subjectAssociationen_US
dc.subjectInsightsen_US
dc.subjectIl23ren_US
dc.titleIL-23R gene polymorphisms in rheumatoid arthritisen_US
dc.typeArticleen_US
dc.identifier.volume42en_US
dc.identifier.issue3en_US
dc.identifier.startpage555en_US
dc.identifier.endpage562en_US
dc.identifier.doi10.1007/s00296-021-04881-9-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid57223341821-
dc.authorscopusid57218161035-
dc.authorscopusid6507009092-
dc.authorscopusid57215001991-
dc.authorscopusid24480613300-
dc.identifier.pmid33978821en_US
dc.identifier.scopus2-s2.0-85105682663en_US
dc.identifier.wosWOS:000650103200002en_US
dc.identifier.scopusqualityQ2-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeArticle-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

7
checked on Nov 16, 2024

WEB OF SCIENCETM
Citations

9
checked on Nov 16, 2024

Page view(s)

58
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.